Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries
JHEP Reports · 2023-02 · 5 (2) · 100623
DOI: 10.1016/j.jhepr.2022.100623 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JHEP Reports, 2023-02. Verfasst von Tim Mitchell und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Liver Studies, King's College Hospital, London, United Kingdom. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic hepatitis B virus disproportionately affects migrant communities in high-income countries, reflecting increased migration from sub-Saharan Africa. Chronic hepatitis B virus is endemic in sub-Saharan Africa, yet the natural history of chronic infection experienced by patients remains incompletely understood, with evidence of variability across genotypes and regions within sub-Saharan Africa. Clinical guidelines recommending treatment thresholds are not specific to sub-Saharan African patients and are based on natural history studies from Western Pacific Asian countries. Access to standard of care treatment is available for sub-Saharan African people with chronic hepatitis B virus infection in high-income countries; however, the evidence base for these treatments was not established in this cohort and areas of uncertainty remain, particularly regarding HCC surveillance and treatment discontinuation. Participation in phase III clinical trials for chronic hepatitis B therapies is almost non-existent amongst sub-Saharan African patients, even when residing in high-income countries that participate in multicentre trials. Engagement with sub-Saharan African patients with chronic hepatitis B in high-income countries is challenging because of the stigma associated with the diagnosis, absence of routine screening systems and the complexities involved in navigating the healthcare system. Nonetheless, improved engagement is critical if we are to achieve global hepatitis B virus elimination.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Liver Studies, King's College Hospital, London, United Kingdom.
- Gastroenterology and Hepatology Department, Royal Perth Hospital, Perth, Australia.
- Department of Inflammation Biology, King's College London, London, UK.
- University College London Medical School, London, UK.
Zitieren
APA
Mitchell, T., Nayagam, J. S., Dusheiko, G., & Agarwal, K. (2023). Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries. JHEP Reports, 5(2), 100623. https://doi.org/10.1016/j.jhepr.2022.100623
Vancouver
Mitchell T, Nayagam JS, Dusheiko G, Agarwal K. Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries. JHEP Reports. 2023;5(2):100623. doi:10.1016/j.jhepr.2022.100623
BibTeX
@article{Mitchell2023,
author = {Mitchell, Tim and Nayagam, Jeremy S and Dusheiko, Geoffrey and Agarwal, Kosh},
title = {Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries},
journal = {JHEP Reports},
year = {2023},
volume = {5},
number = {2},
pages = {100623},
doi = {10.1016/j.jhepr.2022.100623}
}
EUVIMED